PPARγ is required for the differentiation of adipose tissue in vivo and in vitro

Molecular Cell

Volumn 4, Issue 4, 1999, Pages 611-617

  Rosen, Evan D ^a,c   Sarraf, Pasha ^a   Troy, Amy E ^a   Bradwin, Gary ^b   Moore, Kathryn ^d   Milstone, David S ^b   Spiegelman, Bruce M ^a   Mortensen, Richard M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Division of Endocrinology   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DNA; GLUCOSE; ISOBUTYLMETHYLXANTHINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; DRUG MECHANISM; EMBRYO DEVELOPMENT; FEMALE; FUNCTIONAL ASSESSMENT; IN SITU HYBRIDIZATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NULL CELL;

ANIMALIA;

EID: 0033213631     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80211-7     Document Type: Article

References (28)

1. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (1991). Current Protocols in Molecular Biology (New York: John Wiley and Sons).
2. Brockman, J.A., Gupta, R.A., and Dubois, R.N. (1998). Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115, 1049-1055.
3. Chawla, A., Schwarz, E.J., Dimaculangan, D.D., and Lazar, M.A. (1994). Peroxisome proliferator-activated receptor (PPAR) γ: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135, 798-800.
4. Crosby, J.R., Seifeit, R.A., Soriano, P., and Bowen-Pope, D.F.(1998). Chimaeric analysis reveals role of PDGF receptors in all muscle lineages. Nat. Genet. 18, 385-388.
5. Dani, C., Smith, A.G., Dessolin, S., Leroy, P., Staccini, L, Villageois, P., Darimont, C., and Ailhaud, G. (1997). Differentiation of embryonic stem cells into adipocytes in vitro. J. Cell Sci. 110, 1279-1285.
6. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbien, G., and Wahli, W. (1992). Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887.
7. Elstner, E., Muller, C., Koshizuka, K., Williamson, E.A., Park, D., Asou, H., Shintaku, P., Said, J.W., Heber, D., and Koeffler, H.P. (1998). Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA 95, 8806-8811.
8. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812.
9. Hu, E., Tontonoz, P., and Spiegelman, B.M. (1995). Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc. Natl. Acad. Sci. USA 92, 9856-9860.
10. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819.
11. Kliewer, S.A., Sundseth, S.S., Jones, S.A., Brown, P.J., Wisely, G.B., Koble, C.S., Devchand, P., Wahli, W., Willson, T.M., Lenhard, J.M., and Lehmann, J.M. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
12. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956.
13. Mansen, A., Guardiola-Diaz, H., Rafter, J., Branting, C., and Gustafsson, J.A. (1996). Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonie mucosa. Biochem. Biophys. Res. Commun. 222, 844-851.
14. Miles, P.D., Barak, Y., and Evans, R.M. (1999). Metabolic characterization of mice heterozygous for PPARγ deficiency. Diabetes 48, supplement 1, A68.
15. Milstone, D.S., Bradwin, G.,and Mortensen, R.M. (1999). Simultaneous Cre catalyzed recombination of two alleles to restore neomycin sensitivity and facilitate homozygous mutations. Nucleic Acids Res. 27, e10.
16. Mortensen, R.M., Zubiaur, M., Neer, E.J., and Seidman, J.G. (1991). Embryonic stem cells lacking a functional inhibitory G-protein sub-unit (alpha i2) produced by gene targeting of both alleles. Proc. Natl. Acad. Sci. USA 88, 7036-7040.
17. Mortensen, R.M., Conner, D.A., Chao, S., Geisterfer-Lowrance, A.A., and Seidman, J.G. (1992). Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12, 2391-2395.
18. Mueller, E., Sarraf, P.,Tontonoz, P., Evans, R.M., Martin, K.J.,Zhang, M., Fletcher, C., Singer, S., and Spiegelman, B.M. (1998). Terminal differentiation of human breast cancer through PPARγ. Mol. Cell 1, 465-470.
19. Nagy, L, Tontonoz, P., Alvarez, J.G.A., Chen, H., and Evans, R.M. (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229-240.
20. Rosenfield, R.L., Deplewski, D., Kentsis, A., and Ciletti, N. (1998). Mechanisms of androgen induction of sebocyte differentiation. Dermatology 196, 43-46.
21. Rosenfield, R.L., Kentsis, A., Deplewski, D., and Ciletti, N. (1999). Rat preputial sebocyte differentiation involves peroxisome proliferatoractivated receptors. J. Invest. Dermatol. 112, 226-232.
22. Sarraf, P., Mueller, E., Jones, D., King, F.J., DeAngelo, D.J., Partridge, J.B., Holden, S.A., Chen, L.B., Singer, S., Fletcher, C., and Spiegelman, B.M. (1998). Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med. 4, 1046-1052.
23. Sarraf, P., Mueller, E., Smith, W.M., Wright, H.M., Kum, J.B., Aaltonen, L.A., De la Chapelle, A., Spiegelman, B.M., and Eng, C. (1999). Loss-of-function mutations in PPARγ associated with human colon cancer. Mol. Cell 3, 799-804.
24. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M. (1994a). mPPARγ2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
25. Tontonoz, P., Hu, E., and Spiegelman, B.M. (1994b). Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156.
26. Tontonoz, P., Nagy, L., Alvarez, J.G.A., Thomazy, V.A., and Evans, R.M. (1998). PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
27. Wu, Z., Rosen, E.D., Brun, R., Hauser, S., Adelmant, G., Troy, A.E., McKeon, C., Darlington, G.J., and Spiegelman, B.M. (1999). Cross- Regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3, 151-158.
28. Yeh, W.C., Cao, Z., Classon, M., and McKnight, S.L. (1995). Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 15,168-181.